Impact of concomitant replacement of the ascending aorta in patients undergoing aortic valve replacement on operative morbidity and mortality
| Autor: | Andreas Vötsch, Michael Kirnbauer, Paul Puiu, Philipp Krombholz-Reindl, Matthias Neuner, Johannes Steindl, Andreas Winkler, Rainald Seitelberger, Roman Gottardi |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Pulmonary and Respiratory Medicine
medicine.medical_specialty law.invention Postoperative Complications Aortic valve replacement law Internal medicine medicine.artery Ascending aorta Cardiopulmonary bypass Medicine Humans Myocardial infarction Aorta Retrospective Studies Heart Valve Prosthesis Implantation business.industry Atrial fibrillation General Medicine Perioperative medicine.disease Intensive care unit Treatment Outcome Concomitant Aortic Valve Cardiology Surgery Morbidity Cardiology and Cardiovascular Medicine business |
| Zdroj: | European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 61(3) |
| ISSN: | 1873-734X |
| Popis: | OBJECTIVES The aim of this study was to evaluate the impact of concomitant ascending aortic replacement on operative morbidity and mortality in patients undergoing aortic valve replacement (AVR). METHODS We retrospectively analysed our institutional database for all patients undergoing elective isolated AVR and AVR with concomitant replacement of the ascending aorta between January 2009 and May 2020. Patients undergoing surgery for infective endocarditis or requiring hypothermic circulatory arrest were excluded. A 3:1 propensity matching was performed for 688 patients to compare isolated AVR (120 patients) with AVR + ascending aortic replacement (40 patients). RESULTS There were significant differences in median cardiopulmonary bypass (CPB) time [92.5 (75–114) vs 118.5 (104–131) min; P CONCLUSIONS Concomitant replacement of the ascending aorta significantly prolongs CPB and aortic clamp times but does not increase operative morbidity and mortality. Therefore, replacement of a dilated ascending aorta appears to be the most durable and safest treatment option in patients undergoing AVR with an aneurysmatic ascending aorta. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|